Case study of a patient who participated in Ixaka’s REX-001 clinical trial 01/12/2020 Case study of a patient who participated in Ixaka’s REX-001 clinical trial
Ixaka appoints Christian Hoyer Millar as a Non-Executive Director 19/04/2021 Ixaka Ltd, an integrated cell and gene therapy company focused on the natural power of the body to cure disease,… Read More
Leiden University Medical Center and Ixaka enter collaboration to strengthen knowledge of cell therapy candidate REX-001 30/03/2021 Ixaka Ltd and Leiden University Medical Center (LUMC) today announce a research collaboration to expand understanding of Ixaka’s lead multi-cell… Read More